Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Berk

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Clinical and Aesthetic Dermatology|February 11, 2020
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity StudyDavid M Pariser, Lawrence J Green, Edward L Lain, et al.
Pediatric Dermatology|September 13, 2011
Extensive subcutaneous fat necrosis of the newborn associated with therapeutic hypothermiaMarcia Hogeling, Katharine Meddles, David R Berk, et al.
Journal of the American Academy of Dermatology|June 4, 2018
Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatmentMichael H Gold, Mark Lebwohl, Brian S Biesman, et al.
Journal of Drugs in Dermatology : JDD|June 8, 2018
Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0Emil A Tanghetti, Jeffrey S Dover, David J Goldberg, et al.
American Journal of Medical Genetics. Part A|June 13, 2014
Skin findings in Williams syndromeBeth A Kozel, Susan J Bayliss, David R Berk, et al.
Journal of Drugs in Dermatology : JDD|March 15, 2018
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL TrialLeslie Baumann, David J Goldberg, Linda Stein Gold, et al.
American Journal of Medical Genetics. Part A|September 18, 2008
Two new patients with Curry-Jones syndrome with trichoblastoma and medulloblastoma suggest an etiologic role of the sonic hedgehog-patched-GLI pathwayDorothy K Grange, Carol L Clericuzio, Susan J Bayliss, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2016
Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled TrialsLawrence F Eichenfield, Ted Lain, Ellen H Frankel, et al.
Archives of Dermatology|July 19, 2006
Congenital plaque-type glomuvenous malformations presenting in childhoodSusan Bayliss Mallory, Odile Enjolras, Laurence M Boon, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled StudyKim A Papp, Melinda Gooderham, Michael Droege, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Clinical and Aesthetic Dermatology|February 11, 2020
Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity StudyDavid M Pariser, Lawrence J Green, Edward L Lain, et al.
Pediatric Dermatology|September 13, 2011
Extensive subcutaneous fat necrosis of the newborn associated with therapeutic hypothermiaMarcia Hogeling, Katharine Meddles, David R Berk, et al.
Journal of the American Academy of Dermatology|June 4, 2018
Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatmentMichael H Gold, Mark Lebwohl, Brian S Biesman, et al.
Journal of Drugs in Dermatology : JDD|June 8, 2018
Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0Emil A Tanghetti, Jeffrey S Dover, David J Goldberg, et al.
American Journal of Medical Genetics. Part A|June 13, 2014
Skin findings in Williams syndromeBeth A Kozel, Susan J Bayliss, David R Berk, et al.
Journal of Drugs in Dermatology : JDD|March 15, 2018
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL TrialLeslie Baumann, David J Goldberg, Linda Stein Gold, et al.
American Journal of Medical Genetics. Part A|September 18, 2008
Two new patients with Curry-Jones syndrome with trichoblastoma and medulloblastoma suggest an etiologic role of the sonic hedgehog-patched-GLI pathwayDorothy K Grange, Carol L Clericuzio, Susan J Bayliss, et al.
Journal of Drugs in Dermatology : JDD|August 19, 2016
Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled TrialsLawrence F Eichenfield, Ted Lain, Ellen H Frankel, et al.
Archives of Dermatology|July 19, 2006
Congenital plaque-type glomuvenous malformations presenting in childhoodSusan Bayliss Mallory, Odile Enjolras, Laurence M Boon, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled StudyKim A Papp, Melinda Gooderham, Michael Droege, et al.
Pageof 13